Andrew D. Dickinson - 10 Dec 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Financial Officer
Signature: /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol: GILD
Transactions as of: 10 Dec 2022
Net transactions value: -$42,226
Form type: 4
Filing time: 13 Dec 2022, 14:11:17 UTC
Previous filing: 14 Nov 2022
Next filing: 26 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise	$0	+1,027	+1.5%	$0.000000	69,695	10 Dec 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	$42,226	-480	-0.69%	$87.97	69,215	10 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-1,027	-2.3%		44,486	10 Dec 2022	Common Stock	1,027		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.